Nektar Therapeutics Inventory, Raw Materials, Gross
Nektar Therapeutics (NKTR) had Inventory, Raw Materials, Gross of $3.05 million as of 2014-03-31, per its 10-Q filed 2014-05-08.
Discontinued › Notes
us-gaap:InventoryRawMaterials · last filed 2014-05-08
- 2014-03-31: Inventory, Raw Materials, Gross $3.05M.
- 2013-12-31: Inventory, Raw Materials, Gross $3.95M.
- 2013-09-30: Inventory, Raw Materials, Gross $4.91M.
- 2013-06-30: Inventory, Raw Materials, Gross $7.01M.
| Period end | Inventory, Raw Materials, Gross | Inventory, Raw Materials, Gross as first filed |
|---|---|---|
| 2014-03-31 | $3.05M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $3.95M 10-Q · filed 2014-05-08 | |
| 2013-09-30 | $4.91M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $7.01M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $8.13M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $7.49M 10-K · filed 2014-02-27 | |
| 2012-09-30 | $12.08M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $10.18M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $10.83M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $6.66M 10-K · filed 2013-03-01 | $9.75M 10-K · filed 2012-02-29 |
| 2011-09-30 | $9.30M 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $8.98M 10-Q · filed 2011-08-05 | |
| 2010-12-31 | $6.10M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |